{
  "BTM": {
    "ticker": "BTM",
    "news": [],
    "hod": true,
    "float": "5.83M",
    "price": "2.83",
    "time": "01:45:49",
    "isActive": false,
    "firstSeen": "2024-11-12T08:54:46.284Z",
    "lastSeen": "2024-11-12T14:38:19.154Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 294900,
      "Avg. Daily Volume": 92780,
      "Short Float": "5.08%",
      "Short Ratio": "3.18"
    }
  },
  "SUGP": {
    "ticker": "SUGP",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T12:24:27Z",
        "headline": "SU Group Secures Largest Contract In Company History With $4.4M Deal; $3.2M To Be Recognized As Revenue In 2024, Remainder In 2025",
        "id": 41897341,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "SUGP"
        ],
        "updated_at": "2024-11-12T12:24:27Z",
        "url": "https://www.benzinga.com/news/24/11/41897341/su-group-secures-largest-contract-in-company-history-with-4-4m-deal-3-2m-to-be-recognized-as-revenue"
      }
    ],
    "hod": true,
    "float": "3.99M",
    "price": "2.33",
    "time": "00:47:23",
    "isActive": false,
    "firstSeen": "2024-11-12T08:54:46.294Z",
    "lastSeen": "2024-11-12T14:47:08.442Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 4370,
      "Avg. Daily Volume": 74600,
      "Short Float": "0.11%",
      "Short Ratio": "0.06"
    }
  },
  "GOVX": {
    "ticker": "GOVX",
    "news": [
      {
        "author": "Benzinga Insights",
        "content": "",
        "created_at": "2024-11-11T17:02:12Z",
        "headline": "Earnings Preview: Geovax Labs",
        "id": 41883893,
        "images": [],
        "source": "benzinga",
        "summary": " ",
        "symbols": [
          "GOVX"
        ],
        "updated_at": "2024-11-11T17:02:13Z",
        "url": "https://www.benzinga.com/insights/earnings/24/11/41883893/earnings-preview-geovax-labs"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-11T12:50:54Z",
        "headline": "Alliance Global Partners Initiates Coverage On Geovax Labs with Buy Rating, Announces Price Target of $15",
        "id": 41876434,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "GOVX"
        ],
        "updated_at": "2024-11-11T12:50:54Z",
        "url": "https://www.benzinga.com/news/24/11/41876434/alliance-global-partners-initiates-coverage-on-geovax-labs-with-buy-rating-announces-price-target-of"
      }
    ],
    "hod": false,
    "float": "8.48M",
    "price": "3.5",
    "time": "00:37:02",
    "isActive": false,
    "firstSeen": "2024-11-12T08:54:46.297Z",
    "lastSeen": "2024-11-12T14:43:02.014Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 226080,
      "Avg. Daily Volume": 4580000,
      "Short Float": "2.67%",
      "Short Ratio": "0.05"
    }
  },
  "CLSK": {
    "ticker": "CLSK",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-11T15:19:51Z",
        "headline": "CleanSpark Shares Resume Trade",
        "id": 41880673,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "CLSK"
        ],
        "updated_at": "2024-11-11T15:19:51Z",
        "url": "https://www.benzinga.com/trading-ideas/24/11/41880673/cleanspark-shares-resume-trade"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-11T15:10:05Z",
        "headline": "Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: News and Resumption Times",
        "id": 41880353,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "CLSK"
        ],
        "updated_at": "2024-11-11T15:10:05Z",
        "url": "https://www.benzinga.com/24/11/41880353/trading-halt-halt-status-updated-at-10-10-00-am-et-quotation-resumption-news-and-resumption-times"
      }
    ],
    "hod": false,
    "float": "249.32M",
    "price": "18.46",
    "time": "10:00:32",
    "isActive": false,
    "firstSeen": "2024-11-12T09:00:33.563Z",
    "lastSeen": "2024-11-12T09:02:48.965Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 50390000,
      "Avg. Daily Volume": 23580000,
      "Short Float": "20.61%",
      "Short Ratio": "2.14"
    }
  },
  "BTBT": {
    "ticker": "BTBT",
    "news": [],
    "hod": true,
    "float": "147.05M",
    "price": "5.57",
    "time": "10:01:12",
    "isActive": false,
    "firstSeen": "2024-11-12T09:01:21.757Z",
    "lastSeen": "2024-11-12T14:38:19.142Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 26480000,
      "Avg. Daily Volume": 9960000,
      "Short Float": "18.00%",
      "Short Ratio": "2.66"
    }
  },
  "BTCT": {
    "ticker": "BTCT",
    "news": [],
    "hod": false,
    "float": "1.97M",
    "price": "4.77",
    "time": "10:01:10",
    "isActive": true,
    "firstSeen": "2024-11-12T09:01:21.760Z",
    "lastSeen": "2024-11-12T14:57:46.364Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 7210,
      "Avg. Daily Volume": 25000,
      "Short Float": "0.37%",
      "Short Ratio": "0.29"
    }
  },
  "NVAX": {
    "ticker": "NVAX",
    "news": [
      {
        "author": "Benzinga Insights",
        "content": "",
        "created_at": "2024-11-11T21:01:03Z",
        "headline": "Earnings Outlook For Novavax",
        "id": 41887699,
        "images": [],
        "source": "benzinga",
        "summary": " ",
        "symbols": [
          "NVAX"
        ],
        "updated_at": "2024-11-11T21:01:03Z",
        "url": "https://www.benzinga.com/insights/earnings/24/11/41887699/earnings-outlook-for-novavax"
      },
      {
        "author": "Benzinga Insights",
        "content": "",
        "created_at": "2024-11-11T16:00:41Z",
        "headline": "Looking Into Novavax's Recent Short Interest",
        "id": 41882460,
        "images": [
          {
            "size": "large",
            "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2023/movers_image_18.jpeg"
          },
          {
            "size": "small",
            "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/movers_image_18.jpeg"
          },
          {
            "size": "thumb",
            "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2023/movers_image_18.jpeg"
          }
        ],
        "source": "benzinga",
        "summary": " ",
        "symbols": [
          "NVAX"
        ],
        "updated_at": "2024-11-11T16:00:41Z",
        "url": "https://www.benzinga.com/insights/short-sellers/24/11/41882460/looking-into-novavaxs-recent-short-interest"
      },
      {
        "author": "Vandana Singh",
        "content": "",
        "created_at": "2024-11-11T13:58:16Z",
        "headline": "FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial",
        "id": 41878334,
        "images": [
          {
            "size": "large",
            "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/11/Istanbul--Tr---January-29-2021-Novavax-V.jpeg"
          },
          {
            "size": "small",
            "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/11/Istanbul--Tr---January-29-2021-Novavax-V.jpeg"
          },
          {
            "size": "thumb",
            "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/11/Istanbul--Tr---January-29-2021-Novavax-V.jpeg"
          }
        ],
        "source": "benzinga",
        "summary": "FDA lifts clinical hold on Novavax&#39;s COVID-19-influenza combo vaccine, clearing path for Phase 3 trials. Novavax to resume trial activities soon.",
        "symbols": [
          "NVAX"
        ],
        "updated_at": "2024-11-11T13:58:17Z",
        "url": "https://www.benzinga.com/general/biotech/24/11/41878334/fda-gives-green-signal-to-novavaxs-covid-19-influenza-combo-vaccine-late-stage-trial"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-11T13:30:48Z",
        "headline": "U.S. FDA  Has Removed The Clinical Hold On Novavax's IND Application For Its COVID-19-influenza Combination And Stand-Alone Influenza Vaccine Candidates",
        "id": 41877634,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "NVAX"
        ],
        "updated_at": "2024-11-11T13:32:09Z",
        "url": "https://www.benzinga.com/general/biotech/24/11/41877634/u-s-fda-removes-clinical-hold-on-novavaxs-covid-19-influenza-combination-and-stand-alone-influenz"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T11:34:11Z",
        "headline": "HC Wainwright & Co. Reiterates Buy on Novavax, Maintains $19 Price Target",
        "id": 41895749,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "NVAX"
        ],
        "updated_at": "2024-11-12T11:34:11Z",
        "url": "https://www.benzinga.com/news/24/11/41895749/hc-wainwright-co-reiterates-buy-on-novavax-maintains-19-price-target"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T13:03:59Z",
        "headline": "Novavax Q3 2024 GAAP EPS $(0.76) Beats $(0.83) Estimate, Sales $84.51M Beat $65.78M Estimate",
        "id": 41898772,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "NVAX"
        ],
        "updated_at": "2024-11-12T13:03:59Z",
        "url": "https://www.benzinga.com/news/earnings/24/11/41898772/novavax-q3-2024-gaap-eps-0-76-beats-0-83-estimate-sales-84-51m-beat-65-78m-estimate"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T13:06:08Z",
        "headline": "Novavax Expects 2024 Total Revenues Of $650M-$700M Versus Prior Guidance Of $700M-$800M And Consensus Of $761.458M",
        "id": 41898876,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "NVAX"
        ],
        "updated_at": "2024-11-12T13:06:08Z",
        "url": "https://www.benzinga.com/general/biotech/24/11/41898876/novavax-expects-2024-total-revenues-of-650m-700m-versus-prior-guidance-of-700m-800m-and-consensus"
      },
      {
        "author": "Vandana Singh",
        "content": "",
        "created_at": "2024-11-12T14:48:10Z",
        "headline": "Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls",
        "id": 41904976,
        "images": [
          {
            "size": "large",
            "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/12/Novavax-Vaccine-For-Prevention-Of-Corona.jpeg"
          },
          {
            "size": "small",
            "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/12/Novavax-Vaccine-For-Prevention-Of-Corona.jpeg"
          },
          {
            "size": "thumb",
            "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/12/Novavax-Vaccine-For-Prevention-Of-Corona.jpeg"
          }
        ],
        "source": "benzinga",
        "summary": "Novavax reports Q3 2024 sales of $84.5 million, beating estimates, with a net loss of $121 million. EPS improves, FDA approves new vaccine, and revenue guidance is lowered.",
        "symbols": [
          "NVAX"
        ],
        "updated_at": "2024-11-12T14:48:11Z",
        "url": "https://www.benzinga.com/24/11/41904976/novavax-stock-falls-on-lower-2024-revenue-forecast-q3-earnings-beat-consensus-estimates"
      }
    ],
    "hod": false,
    "float": "153.03M",
    "price": "9.48",
    "time": "10:02:05",
    "isActive": false,
    "firstSeen": "2024-11-12T09:02:48.959Z",
    "lastSeen": "2024-11-12T09:02:48.959Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 35720000,
      "Avg. Daily Volume": 6570000,
      "Short Float": "23.34%",
      "Short Ratio": "5.44"
    }
  },
  "MAXN": {
    "ticker": "MAXN",
    "news": [],
    "hod": true,
    "float": "4.54M",
    "price": "13.21",
    "time": "10:07:22",
    "isActive": false,
    "firstSeen": "2024-11-12T09:07:24.482Z",
    "lastSeen": "2024-11-12T14:43:02.020Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 992660,
      "Avg. Daily Volume": 725560,
      "Short Float": "6.60%",
      "Short Ratio": "1.37"
    }
  },
  "XBP": {
    "ticker": "XBP",
    "news": [],
    "hod": false,
    "float": "8.35M",
    "price": "1.82",
    "time": "10:13:42",
    "isActive": false,
    "firstSeen": "2024-11-12T09:14:19.804Z",
    "lastSeen": "2024-11-12T13:30:20.621Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 21880,
      "Avg. Daily Volume": 24730,
      "Short Float": "0.26%",
      "Short Ratio": "0.88"
    }
  },
  "BAER": {
    "ticker": "BAER",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-11T21:15:29Z",
        "headline": "Bridger Aerospace Gr Raises FY2024 Sales Guidance from $70.00M-86.00M to $90.00M-95.00M",
        "id": 41888022,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "BAER"
        ],
        "updated_at": "2024-11-11T21:15:30Z",
        "url": "https://www.benzinga.com/news/24/11/41888022/bridger-aerospace-gr-raises-fy2024-sales-guidance-from-70-00m-86-00m-to-90-00m-95-00m"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-11T21:13:51Z",
        "headline": "Bridger Aerospace Gr Q3 2024 GAAP EPS $0.31 Misses $0.46 Estimate, Sales $64.507M Beat $57.500M Estimate",
        "id": 41888000,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "BAER"
        ],
        "updated_at": "2024-11-11T21:13:51Z",
        "url": "https://www.benzinga.com/news/earnings/24/11/41888000/bridger-aerospace-gr-q3-2024-gaap-eps-0-31-misses-0-46-estimate-sales-64-507m-beat-57-500m-estimate"
      }
    ],
    "hod": false,
    "float": "12.64M",
    "price": "4.7",
    "time": "10:21:22",
    "isActive": false,
    "firstSeen": "2024-11-12T09:21:42.921Z",
    "lastSeen": "2024-11-12T09:21:42.921Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 710660,
      "Avg. Daily Volume": 90140,
      "Short Float": "5.54%",
      "Short Ratio": "7.88"
    }
  },
  "EVGO": {
    "ticker": "EVGO",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T12:03:41Z",
        "headline": "EVgo Q3 2024 GAAP EPS $(0.11) Beats $(0.12) Estimate, Sales $67.535M Beat $65.952M Estimate",
        "id": 41896624,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "EVGO"
        ],
        "updated_at": "2024-11-12T12:03:41Z",
        "url": "https://www.benzinga.com/news/earnings/24/11/41896624/evgo-q3-2024-gaap-eps-0-11-beats-0-12-estimate-sales-67-535m-beat-65-952m-estimate"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T12:23:42Z",
        "headline": "EVgo Raised The Midpoint Of FY24 Total Revenue Guidance By $2.5M  To $250M-$265M Vs. $257.34M Estimate (Prior View: $240M-$270M)",
        "id": 41897294,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "EVGO"
        ],
        "updated_at": "2024-11-12T12:23:42Z",
        "url": "https://www.benzinga.com/news/24/11/41897294/evgo-raised-the-midpoint-of-fy24-total-revenue-guidance-by-2-5m-to-250m-265m-vs-257-34m-estimate-pri"
      }
    ],
    "hod": false,
    "float": "99.92M",
    "price": "5.77",
    "time": "13:11:43",
    "isActive": false,
    "firstSeen": "2024-11-12T12:11:47.963Z",
    "lastSeen": "2024-11-12T14:46:15.007Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 32689999.999999996,
      "Avg. Daily Volume": 6960000,
      "Short Float": "32.72%",
      "Short Ratio": "4.70"
    }
  },
  "AGFY": {
    "ticker": "AGFY",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T12:20:23Z",
        "headline": "Agrify Corporation To Acquire Señorita Brand Of THC Beverages, Expanding Presence In Hemp-Derived Legal THC Market; Deal Expected To Close By Year-End; Financial Terms Not Disclosed",
        "id": 41897251,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "AGFY"
        ],
        "updated_at": "2024-11-12T12:20:24Z",
        "url": "https://www.benzinga.com/m-a/24/11/41897251/agrify-corporation-to-acquire-se-orita-brand-of-thc-beverages-expanding-presence-in-hemp-derived-leg"
      }
    ],
    "hod": false,
    "float": "1.33M",
    "price": "5.65",
    "time": "13:30:41",
    "isActive": false,
    "firstSeen": "2024-11-12T12:31:03.384Z",
    "lastSeen": "2024-11-12T13:13:14.478Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 27410,
      "Avg. Daily Volume": 27420,
      "Short Float": "2.06%",
      "Short Ratio": "1.00"
    }
  },
  "ZENA": {
    "ticker": "ZENA",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T12:46:02Z",
        "headline": "ZenaTech Expands Portfolio with Acquisition Of InterlinkONE And Interactive Systems, Integrates With AI Drone For Autonomous Inventory",
        "id": 41898040,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "ZENA"
        ],
        "updated_at": "2024-11-12T12:46:03Z",
        "url": "https://www.benzinga.com/m-a/24/11/41898040/zenatech-expands-portfolio-with-acquisition-of-interlinkone-and-interactive-systems-integrates-with"
      }
    ],
    "hod": false,
    "float": "8.23M",
    "price": "2.23",
    "time": "13:34:57",
    "isActive": false,
    "firstSeen": "2024-11-12T12:35:38.182Z",
    "lastSeen": "2024-11-12T12:35:38.182Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 570530,
      "Avg. Daily Volume": 4950000,
      "Short Float": "29.61%",
      "Short Ratio": "0.12"
    }
  },
  "TSHA": {
    "ticker": "TSHA",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T11:21:15Z",
        "headline": "Needham Reiterates Buy on Taysha Gene Therapies, Maintains $6 Price Target",
        "id": 41895599,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "TSHA"
        ],
        "updated_at": "2024-11-12T11:21:15Z",
        "url": "https://www.benzinga.com/news/24/11/41895599/needham-reiterates-buy-on-taysha-gene-therapies-maintains-6-price-target"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T13:41:06Z",
        "headline": "Cantor Fitzgerald Reiterates Overweight on Taysha Gene Therapies, Maintains $7 Price Target",
        "id": 41900133,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "TSHA"
        ],
        "updated_at": "2024-11-12T13:41:07Z",
        "url": "https://www.benzinga.com/news/24/11/41900133/cantor-fitzgerald-reiterates-overweight-on-taysha-gene-therapies-maintains-7-price-target"
      }
    ],
    "hod": false,
    "float": "158.49M",
    "price": "2.16",
    "time": "13:43:47",
    "isActive": false,
    "firstSeen": "2024-11-12T12:44:20.888Z",
    "lastSeen": "2024-11-12T14:49:32.935Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 17640000,
      "Avg. Daily Volume": 1540000,
      "Short Float": "11.13%",
      "Short Ratio": "11.48"
    }
  },
  "AMPX": {
    "ticker": "AMPX",
    "news": [],
    "hod": false,
    "float": "75.28M",
    "price": "2.68",
    "time": "14:01:34",
    "isActive": false,
    "firstSeen": "2024-11-12T13:02:08.666Z",
    "lastSeen": "2024-11-12T14:34:25.683Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 4800000,
      "Avg. Daily Volume": 1260000,
      "Short Float": "6.08%",
      "Short Ratio": "3.80"
    }
  },
  "LEDS": {
    "ticker": "LEDS",
    "news": [],
    "hod": false,
    "float": "3.35M",
    "price": "1.77",
    "time": "14:22:57",
    "isActive": false,
    "firstSeen": "2024-11-12T13:23:26.142Z",
    "lastSeen": "2024-11-12T14:31:07.234Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 2670,
      "Avg. Daily Volume": 12970,
      "Short Float": "0.08%",
      "Short Ratio": "0.21"
    }
  },
  "SIDU": {
    "ticker": "SIDU",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T13:36:34Z",
        "headline": "Sidus Space Chosen As Exclusive Builder For Lonestar's Lunar Data Storage Spacecraft Fleet; Six LizzieSat Satellites To Deliver Critical Data Storage And Disaster Recovery Solutions",
        "id": 41900033,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "SIDU"
        ],
        "updated_at": "2024-11-12T13:36:35Z",
        "url": "https://www.benzinga.com/news/24/11/41900033/sidus-space-chosen-as-exclusive-builder-for-lonestars-lunar-data-storage-spacecraft-fleet-six-lizzie"
      }
    ],
    "hod": false,
    "float": "3.75M",
    "price": "2.57",
    "time": "14:31:44",
    "isActive": false,
    "firstSeen": "2024-11-12T13:31:46.469Z",
    "lastSeen": "2024-11-12T13:51:36.807Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 504970,
      "Avg. Daily Volume": 439420,
      "Short Float": "13.47%",
      "Short Ratio": "1.15"
    }
  },
  "RSLS": {
    "ticker": "RSLS",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-11T13:37:20Z",
        "headline": "ReShape Lifesciences shares are trading higher after the NIH, with the University of Southern California's Center for Autonomic Nerve Recording and Stimulation Systems, awarded the company an approximately $241,000 supplementary grant for the development of the next-generation electrodes for ReShape's Diabetes Bloc-Stim Neuromodulation device.",
        "id": 41877752,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "RSLS"
        ],
        "updated_at": "2024-11-11T15:02:03Z",
        "url": "https://www.benzinga.com/wiim/24/11/41877752/reshape-lifesciences-shares-are-trading-higher-after-the-nih-with-the-university-of-southern-califor"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-11T13:33:17Z",
        "headline": "ReShape Lifesciences Secures $241K NIH Grant With USC's CARSS To Advance Next-Gen Electrodes For Diabetes Bloc-Stim Neuromodulation Technology",
        "id": 41877675,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "RSLS"
        ],
        "updated_at": "2024-11-11T13:33:17Z",
        "url": "https://www.benzinga.com/news/24/11/41877675/reshape-lifesciences-secures-241k-nih-grant-with-uscs-carss-to-advance-next-gen-electrodes-for-diabe"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T13:32:01Z",
        "headline": "ReShape Lifesciences Gains Health Canada Approval For Next-Gen Lap-Band 2.0 FLEX; Enhanced Design With Flex Technology Aims To Improve Patient Experience And Prepares For Canadian Launch",
        "id": 41899960,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "RSLS"
        ],
        "updated_at": "2024-11-12T13:32:01Z",
        "url": "https://www.benzinga.com/news/24/11/41899960/reshape-lifesciences-gains-health-canada-approval-for-next-gen-lap-band-2-0-flex-enhanced-design-wit"
      }
    ],
    "hod": false,
    "float": "468.95K",
    "price": "6.19",
    "time": "14:32:35",
    "isActive": false,
    "firstSeen": "2024-11-12T13:32:52.152Z",
    "lastSeen": "2024-11-12T13:32:52.152Z",
    "filings": [
      {
        "formType": "S-3",
        "description": "Registration statement under Securities Act of 1933\nAcc-no: 0001544784-24-000045 (33 Act)  Size: 287 KB",
        "date": "2024-05-09"
      }
    ],
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 25010,
      "Avg. Daily Volume": 187250,
      "Short Float": "5.32%",
      "Short Ratio": "0.13"
    }
  },
  "VSTE": {
    "ticker": "VSTE",
    "news": [],
    "hod": false,
    "float": "2.08M",
    "price": "1.9",
    "time": "15:01:35",
    "isActive": false,
    "firstSeen": "2024-11-12T14:01:44.739Z",
    "lastSeen": "2024-11-12T14:01:44.739Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 692000,
      "Avg. Daily Volume": 917450,
      "Short Float": "33.27%",
      "Short Ratio": "0.75"
    }
  },
  "NVRO": {
    "ticker": "NVRO",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T13:11:23Z",
        "headline": "Nevro Has Received CE Mark Certification In Europe For Its HFX iQ Spinal Cord Stimulation System",
        "id": 41899141,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "NVRO"
        ],
        "updated_at": "2024-11-12T13:11:24Z",
        "url": "https://www.benzinga.com/news/24/11/41899141/nevro-has-received-ce-mark-certification-in-europe-for-its-hfx-iq-spinal-cord-stimulation-system"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T12:35:52Z",
        "headline": "Baird Maintains Neutral on Nevro, Raises Price Target to $6",
        "id": 41897621,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "NVRO"
        ],
        "updated_at": "2024-11-12T12:35:53Z",
        "url": "https://www.benzinga.com/news/24/11/41897621/baird-maintains-neutral-on-nevro-raises-price-target-to-6"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T11:59:29Z",
        "headline": "Piper Sandler Maintains Underweight on Nevro, Lowers Price Target to $6",
        "id": 41896340,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "NVRO"
        ],
        "updated_at": "2024-11-12T11:59:30Z",
        "url": "https://www.benzinga.com/news/24/11/41896340/piper-sandler-maintains-underweight-on-nevro-lowers-price-target-to-6"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-11T21:11:34Z",
        "headline": "Nevro Sees FY24 Revenue $400M-$405M Vs $402.55M Est.",
        "id": 41887983,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "NVRO"
        ],
        "updated_at": "2024-11-11T21:11:34Z",
        "url": "https://www.benzinga.com/news/24/11/41887983/nevro-sees-fy24-revenue-400m-405m-vs-402-55m-est"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-11T21:08:02Z",
        "headline": "Nevro Q3 EPS $(0.41) Beats $(0.76) Estimate, Sales $96.91M Beat $93.07M Estimate",
        "id": 41887866,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "NVRO"
        ],
        "updated_at": "2024-11-11T21:08:03Z",
        "url": "https://www.benzinga.com/news/earnings/24/11/41887866/nevro-q3-eps-0-41-beats-0-76-estimate-sales-96-91m-beat-93-07m-estimate"
      }
    ],
    "hod": false,
    "float": "35.17M",
    "price": "6.73",
    "time": "15:20:25",
    "isActive": false,
    "firstSeen": "2024-11-12T14:20:38.181Z",
    "lastSeen": "2024-11-12T14:20:38.181Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 3140000,
      "Avg. Daily Volume": 612490,
      "Short Float": "8.91%",
      "Short Ratio": "5.12"
    }
  },
  "AZI": {
    "ticker": "AZI",
    "news": [],
    "hod": false,
    "float": "29.25M",
    "price": "3.23",
    "time": "15:20:43",
    "isActive": false,
    "firstSeen": "2024-11-12T14:21:45.623Z",
    "lastSeen": "2024-11-12T14:21:45.623Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 3360,
      "Avg. Daily Volume": 378140,
      "Short Float": "N/A",
      "Short Ratio": "0.01"
    }
  },
  "CCLD": {
    "ticker": "CCLD",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T12:14:49Z",
        "headline": "CareCloud Sees FY24 Revenue $109M-$111M Vs $111.119M Est.",
        "id": 41897038,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "CCLD"
        ],
        "updated_at": "2024-11-12T12:14:50Z",
        "url": "https://www.benzinga.com/news/24/11/41897038/carecloud-sees-fy24-revenue-109m-111m-vs-111-119m-est"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T12:07:58Z",
        "headline": "CareCloud Q3 2024 Adj. EPS $0.21 Beats $(0.14) Estimate, Sales $28.546M Beat $28.525M Estimate",
        "id": 41896693,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "CCLD"
        ],
        "updated_at": "2024-11-12T12:07:58Z",
        "url": "https://www.benzinga.com/news/earnings/24/11/41896693/carecloud-q3-2024-adj-eps-0-21-beats-0-14-estimate-sales-28-546m-beat-28-525m-estimate"
      }
    ],
    "hod": false,
    "float": "8.29M",
    "price": "3.27",
    "time": "15:25:31",
    "isActive": false,
    "firstSeen": "2024-11-12T14:25:49.015Z",
    "lastSeen": "2024-11-12T14:29:34.571Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 50590,
      "Avg. Daily Volume": 78510,
      "Short Float": "0.61%",
      "Short Ratio": "0.64"
    }
  },
  "PLL": {
    "ticker": "PLL",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T11:53:18Z",
        "headline": "Piedmont Lithium Q3 2024 Adj. EPS $(0.42) Beats $(0.58) Estimate, Sales $27.700M Miss $28.189M Estimate",
        "id": 41896258,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "PLL"
        ],
        "updated_at": "2024-11-12T11:53:18Z",
        "url": "https://www.benzinga.com/news/earnings/24/11/41896258/piedmont-lithium-q3-2024-adj-eps-0-42-beats-0-58-estimate-sales-27-700m-miss-28-189m-estimate"
      }
    ],
    "hod": false,
    "float": "17.81M",
    "price": "12.86",
    "time": "15:27:44",
    "isActive": false,
    "firstSeen": "2024-11-12T14:27:52.694Z",
    "lastSeen": "2024-11-12T14:28:38.216Z",
    "filings": [
      {
        "formType": "S-3",
        "description": "Registration statement under Securities Act of 1933\nAcc-no: 0001140361-24-041077 (33 Act)  Size: 1 MB",
        "date": "2024-09-13"
      }
    ],
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 3640000,
      "Avg. Daily Volume": 825830,
      "Short Float": "20.44%",
      "Short Ratio": "4.41"
    }
  },
  "TGI": {
    "ticker": "TGI",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T11:16:32Z",
        "headline": "Triumph Group Continues To Expect FY25 Net Sales Of Approximately $1.2B (Est $1.209B), Raises Adjusted EPS Outlook From $0.52 To Range Of $0.70 - $0.76 (Est $0.41)",
        "id": 41895371,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "TGI"
        ],
        "updated_at": "2024-11-12T11:16:32Z",
        "url": "https://www.benzinga.com/news/24/11/41895371/triumph-group-continues-to-expect-fy25-net-sales-of-approximately-1-2b-est-1-209b-raises-adjusted-ep"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T11:02:08Z",
        "headline": "Triumph Group Q2 2025 Adj EPS $0.20 Beats $0.01 Estimate, Sales $287.50M Beat $283.09M Estimate",
        "id": 41895086,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "TGI"
        ],
        "updated_at": "2024-11-12T11:02:08Z",
        "url": "https://www.benzinga.com/news/earnings/24/11/41895086/triumph-group-q2-2025-adj-eps-0-20-beats-0-01-estimate-sales-287-50m-beat-283-09m-estimate"
      }
    ],
    "hod": false,
    "float": "75.68M",
    "price": "19.35",
    "time": "15:28:14",
    "isActive": false,
    "firstSeen": "2024-11-12T14:28:38.216Z",
    "lastSeen": "2024-11-12T14:28:38.216Z",
    "filings": [
      {
        "formType": "S-3ASR",
        "description": "Automatic shelf registration statement of securities of well-known seasoned issuers\nAcc-no: 0001193125-24-175120 (33 Act)  Size: 646 KB",
        "date": "2024-07-03"
      }
    ],
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 8720000,
      "Avg. Daily Volume": 1010000,
      "Short Float": "11.52%",
      "Short Ratio": "8.60"
    }
  },
  "RVNC": {
    "ticker": "RVNC",
    "news": [],
    "hod": true,
    "float": "95.70M",
    "price": "4.18",
    "time": "15:29:51",
    "isActive": false,
    "firstSeen": "2024-11-12T14:31:07.234Z",
    "lastSeen": "2024-11-12T14:48:12.816Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 10000000,
      "Avg. Daily Volume": 4650000,
      "Short Float": "10.45%",
      "Short Ratio": "2.15"
    }
  },
  "ALT": {
    "ticker": "ALT",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T13:47:53Z",
        "headline": "UBS Initiates Coverage On Altimmune with Buy Rating, Announces Price Target of $26",
        "id": 41900493,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "ALT"
        ],
        "updated_at": "2024-11-12T13:47:54Z",
        "url": "https://www.benzinga.com/news/24/11/41900493/ubs-initiates-coverage-on-altimmune-with-buy-rating-announces-price-target-of-26"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T12:01:57Z",
        "headline": "Altimmune Q3 2024 GAAP EPS $(0.32) Beats $(0.36) Estimate, Sales $5.000K Beat $833.330 Estimate",
        "id": 41896547,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "ALT"
        ],
        "updated_at": "2024-11-12T12:01:57Z",
        "url": "https://www.benzinga.com/news/earnings/24/11/41896547/altimmune-q3-2024-gaap-eps-0-32-beats-0-36-estimate-sales-5-000k-beat-833-330-estimate"
      }
    ],
    "hod": false,
    "float": "70.48M",
    "price": "8.8",
    "time": "15:34:23",
    "isActive": true,
    "firstSeen": "2024-11-12T14:34:25.678Z",
    "lastSeen": "2024-11-12T14:57:10.360Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 22940000,
      "Avg. Daily Volume": 2190000,
      "Short Float": "32.54%",
      "Short Ratio": "10.49"
    }
  },
  "GENI": {
    "ticker": "GENI",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T12:48:41Z",
        "headline": "Needham Reiterates Buy on Genius Sports, Maintains $9 Price Target",
        "id": 41898065,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "GENI"
        ],
        "updated_at": "2024-11-12T12:48:42Z",
        "url": "https://www.benzinga.com/news/24/11/41898065/needham-reiterates-buy-on-genius-sports-maintains-9-price-target"
      }
    ],
    "hod": true,
    "float": "184.54M",
    "price": "9.66",
    "time": "15:35:46",
    "isActive": false,
    "firstSeen": "2024-11-12T14:35:57.035Z",
    "lastSeen": "2024-11-12T14:39:48.662Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 24430000,
      "Avg. Daily Volume": 2710000,
      "Short Float": "13.24%",
      "Short Ratio": "9.00"
    }
  },
  "ASPI": {
    "ticker": "ASPI",
    "news": [],
    "hod": true,
    "float": "44.99M",
    "price": "8.93",
    "time": "15:41:01",
    "isActive": false,
    "firstSeen": "2024-11-12T14:41:43.626Z",
    "lastSeen": "2024-11-12T14:41:43.626Z",
    "filings": [
      {
        "formType": "S-3MEF",
        "description": "Registration adding securities to prior Form S-3 registration [Rule 462(b)]\nAcc-no: 0001477932-24-006805 (33 Act)  Size: 110 KB",
        "date": "2024-10-31"
      }
    ],
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 10800000,
      "Avg. Daily Volume": 2190000,
      "Short Float": "25.63%",
      "Short Ratio": "4.93"
    }
  },
  "MULN": {
    "ticker": "MULN",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-12T14:19:51Z",
        "headline": "Mullen's Class 1 EV Cargo Van Now Available For Rental On Turo, Meeting Rising Demand For Compact, Sustainable Urban Transport",
        "id": 41902481,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "MULN"
        ],
        "updated_at": "2024-11-12T14:19:52Z",
        "url": "https://www.benzinga.com/news/24/11/41902481/mullens-class-1-ev-cargo-van-now-available-for-rental-on-turo-meeting-rising-demand-for-compact-sust"
      }
    ],
    "hod": true,
    "float": "5.25M",
    "price": "2.03",
    "time": "15:47:19",
    "isActive": true,
    "firstSeen": "2024-11-12T14:48:12.816Z",
    "lastSeen": "2024-11-12T14:55:40.324Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 1090000,
      "Avg. Daily Volume": 1490000,
      "Short Float": "20.77%",
      "Short Ratio": "0.73"
    }
  },
  "SGMO": {
    "ticker": "SGMO",
    "news": [
      {
        "author": "Benzinga Insights",
        "content": "",
        "created_at": "2024-11-11T16:05:07Z",
        "headline": "Sangamo Therapeutics's Earnings Outlook",
        "id": 41882602,
        "images": [],
        "source": "benzinga",
        "summary": " ",
        "symbols": [
          "SGMO"
        ],
        "updated_at": "2024-11-11T16:05:07Z",
        "url": "https://www.benzinga.com/insights/earnings/24/11/41882602/sangamo-therapeuticss-earnings-outlook"
      }
    ],
    "hod": true,
    "float": "198.63M",
    "price": "2.8",
    "time": "15:49:27",
    "isActive": false,
    "firstSeen": "2024-11-12T14:49:32.935Z",
    "lastSeen": "2024-11-12T14:50:35.648Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 18980000,
      "Avg. Daily Volume": 8980000,
      "Short Float": "9.55%",
      "Short Ratio": "2.11"
    }
  },
  "LTBR": {
    "ticker": "LTBR",
    "news": [],
    "hod": false,
    "float": "13.64M",
    "price": "9.24",
    "time": "15:55:34",
    "isActive": true,
    "firstSeen": "2024-11-12T14:55:40.319Z",
    "lastSeen": "2024-11-12T14:55:40.319Z",
    "filings": [
      {
        "formType": "S-3",
        "description": "Registration statement under Securities Act of 1933\nAcc-no: 0001477932-24-001619 (33 Act)  Size: 497 KB",
        "date": "2024-03-29"
      }
    ],
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 1310000,
      "Avg. Daily Volume": 1160000,
      "Short Float": "9.60%",
      "Short Ratio": "1.13"
    }
  },
  "CDXC": {
    "ticker": "CDXC",
    "news": [],
    "hod": false,
    "float": "48.22M",
    "price": "7.42",
    "time": "15:57:01",
    "isActive": true,
    "firstSeen": "2024-11-12T14:57:10.350Z",
    "lastSeen": "2024-11-12T14:57:10.350Z",
    "shorts": {
      "Settlement Date": "Oct 31, 2024",
      "Short Interest": 2600000,
      "Avg. Daily Volume": 268000,
      "Short Float": "5.40%",
      "Short Ratio": "9.71"
    }
  }
}